These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32934746)

  • 1. Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A
    Verma A; Najahi-Missaoui W; Cummings BS; Somanath PR
    Oncol Lett; 2020 Nov; 20(5):179. PubMed ID: 32934746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
    Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
    Mock JN; Costyn LJ; Wilding SL; Arnold RD; Cummings BS
    Integr Biol (Camb); 2013 Jan; 5(1):172-82. PubMed ID: 22890797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.
    Al-Azayzih A; Missaoui WN; Cummings BS; Somanath PR
    Nanomedicine; 2016 Jul; 12(5):1231-1239. PubMed ID: 26949163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
    Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
    Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate.
    Wang Y; Gratzke C; Tamalunas A; Wiemer N; Ciotkowska A; Rutz B; Waidelich R; Strittmatter F; Liu C; Stief CG; Hennenberg M
    PLoS One; 2016; 11(4):e0153312. PubMed ID: 27071060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.
    Verma A; Artham S; Alwhaibi A; Adil MS; Cummings BS; Somanath PR
    Biochem Pharmacol; 2020 Jul; 177():113943. PubMed ID: 32240651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
    Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
    Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes.
    Singhal R; Kandel ES
    Oncotarget; 2012 Jul; 3(7):700-8. PubMed ID: 22869096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice.
    Kedar E; Braun E; Rutkowski Y; Emanuel N; Barenholz Y
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):115-24. PubMed ID: 7804526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.
    Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS
    Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.
    Kalwat MA; Yoder SM; Wang Z; Thurmond DC
    Biochem Pharmacol; 2013 Mar; 85(6):808-16. PubMed ID: 23246867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells.
    Tunduguru R; Chiu TT; Ramalingam L; Elmendorf JS; Klip A; Thurmond DC
    Biochem Pharmacol; 2014 Nov; 92(2):380-8. PubMed ID: 25199455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
    Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
    Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
    Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes.
    Kedar E; Rutkowski Y; Braun E; Emanuel N; Barenholz Y
    J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):47-59. PubMed ID: 8081559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory phospholipase A
    Østrem RG; Parhamifar L; Pourhassan H; Clergeaud G; Nielsen OL; Kjær A; Hansen AE; Andresen TL
    J Control Release; 2017 Sep; 262():212-221. PubMed ID: 28754610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the use of sPLA
    Pourhassan H; Clergeaud G; Hansen AE; Østrem RG; Fliedner FP; Melander F; Nielsen OL; O'Sullivan CK; Kjær A; Andresen TL
    J Control Release; 2017 Sep; 261():163-173. PubMed ID: 28662900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.